Getty and Photo Illustration by Becky Jiras Welcome to Show the Receipts, a new series where we ask interesting people to ...
MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
New 2-year data show the long-term effects of bimekizumab on hidradenitis suppurativa, indicating its potential as a valuable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback